Powder: -20°C for 3 years | In solvent: -80°C for 1 year
ML417 is a selective and brain penetrant agonist of D3 Dopamine (EC50 : 38 nM).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | In stock | $ 34.00 | |
5 mg | In stock | $ 55.00 | |
10 mg | In stock | $ 98.00 | |
25 mg | In stock | $ 193.00 | |
50 mg | In stock | $ 355.00 | |
100 mg | In stock | $ 527.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 82.00 |
Description | ML417 is a selective and brain penetrant agonist of D3 Dopamine (EC50 : 38 nM). |
Targets&IC50 | D3:38 nM(EC50) |
In vitro | Molecular modeling suggests that ML417 interacts with the D3R in a unique manner, possibly explaining its remarkable selectivity.?ML417 was also found to protect against neurodegeneration of dopaminergic neurons derived from iPSCs.?Together with promising pharmacokinetics and toxicology profiles, these results suggest that ML417 is a novel and uniquely selective D3R agonist that may serve as both a research tool and a therapeutic lead for the treatment of neuropsychiatric disorders. |
Molecular Weight | 379.45 |
Formula | C22H25N3O3 |
CAS No. | 1386162-69-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (131.77 mM), Sonification is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
ML417 1386162-69-1 GPCR/G Protein Neuroscience Dopamine Receptor Arrestin neuroprotection dopaminergic β-arrestin translocation phosphorylation ML-417 ML 417 neurons Inhibitor inhibit inhibitor